Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: Randomised controlled trial

Michael E. Farkouh*, Howard Kirshner, Robert A. Harrington, Sean Ruland, Freek W A Verheugt, Thomas J. Schnitzer, Gerd R. Burmester, Eduardo Mysler, Marc C. Hochberg, Michael Doherty, Elena Ehrsam, Xavier Gitton, Gerhard Krammer, Bernhard Mellein, Alberto Gimona, Patrice Matchaba, Christopher J. Hawkey, James H. Chesebro

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

479 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: Randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences